These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8544770)

  • 21. Concentrations of striatal catecholamines in rats given manganese chloride through drinking water.
    Chandra SV; Shukla GS
    J Neurochem; 1981 Feb; 36(2):683-7. PubMed ID: 7463083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Seasonal fluctuations in the catecholamine content in the brain of white rats].
    Otter MIa; Nurmand LB
    Biull Eksp Biol Med; 1980 Feb; 89(2):215-7. PubMed ID: 7370426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new method for rapidly and simultaneously decreasing serotonin and catecholamine synthesis in humans.
    Leyton M; Pun VK; Benkelfat C; Young SN
    J Psychiatry Neurosci; 2003 Nov; 28(6):464-7. PubMed ID: 14631457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase of catecholamines in mouse brain by systemic administration of gamma-glutamyl L-3,4-dihydroxyphenylalanine.
    Ichinose H; Togari A; Suzuki H; Kumagai H; Nagatsu T
    J Neurochem; 1987 Sep; 49(3):928-32. PubMed ID: 3112308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of tyrosine on brain catecholamine turnover in reserpine-treated rats.
    Oishi T; Wurtman RJ
    J Neural Transm; 1982; 53(2-3):101-8. PubMed ID: 7077311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release.
    McTavish SF; Cowen PJ; Sharp T
    Psychopharmacology (Berl); 1999 Jan; 141(2):182-8. PubMed ID: 9952043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments.
    Karoum F; Korpi ER; Linnoila M; Chuang LW; Wyatt RJ
    Eur J Pharmacol; 1984 Apr; 100(2):137-44. PubMed ID: 6234178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catecholamine concentrations and the activity of tyrosine hydroxylase after an increase in the concentration of tyrosine in rat tissues.
    Dairman W
    Br J Pharmacol; 1972 Feb; 44(2):307-10. PubMed ID: 4148919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic cocaine and rat brain catecholamines: long-term reduction in hypothalamic and frontal cortex dopamine metabolism.
    Karoum F; Suddath RL; Wyatt RJ
    Eur J Pharmacol; 1990 Sep; 186(1):1-8. PubMed ID: 2282931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction in the cerebral metabolism of the biogenic amines: effect of intravenous infusion of L-tryptophan on tryptophan and tyrosine in brain and body fluids.
    Moir AT
    Br J Pharmacol; 1971 Dec; 43(4):724-31. PubMed ID: 5152024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of experimental diabetes on brain levels of monoamine neurotransmitters and their precursor amino acids during tryptophan loading.
    Masiello P; Balestreri E; Bacciola D; Bergamini E
    Acta Diabetol Lat; 1987; 24(1):43-50. PubMed ID: 2887079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of p-nitromethylamphetamine on biogenic amines and their amino-acid precursors in rat brain.
    Leonard BE; Shallice SA
    Br J Pharmacol; 1971 Dec; 43(4):732-8. PubMed ID: 5152025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the in vivo biosynthesis and changes of catecholamine levels in rat brain after alpha-methyl-p-tyrosine; time- and dose-response relationships.
    Widerlöv E; Lewander T
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):111-23. PubMed ID: 703854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders.
    Lambert G; Johansson M; Agren H; Friberg P
    Arch Gen Psychiatry; 2000 Aug; 57(8):787-93. PubMed ID: 10920468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low concentrations of serum tyrosine in neuroleptic-free schizophrenics with an early onset.
    Wei J; Xu H; Ramchand CN; Hemmings GP
    Schizophr Res; 1995 Feb; 14(3):257-60. PubMed ID: 7766538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alteration of rat brain catecholamine metabolism during exposure to hypobaric hypoxia.
    Cymerman A; Robinson SM; McCullough D
    Can J Physiol Pharmacol; 1972 Apr; 50(4):321-7. PubMed ID: 4402610
    [No Abstract]   [Full Text] [Related]  

  • 37. Rapid determination of norepinephrine, dopamine, serotonin, their precursor amino acids, and related metabolites in discrete brain areas of mice within ten minutes by HPLC with electrochemical detection.
    Murai S; Saito H; Masuda Y; Itoh T
    J Neurochem; 1988 Feb; 50(2):473-9. PubMed ID: 2447240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In rats chronically treated with clozapine, tyrosine depletion attenuates the clozapine-induced in vivo increase in prefrontal cortex dopamine and norepinephrine levels.
    Jaskiw GE; Kirkbride B; Bongiovanni R
    Psychopharmacology (Berl); 2006 May; 185(4):416-22. PubMed ID: 16541248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain.
    Fernstrom JD; Fernstrom MH
    J Nutr; 2007 Jun; 137(6 Suppl 1):1539S-1547S; discussion 1548S. PubMed ID: 17513421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered precursor availability and metabolism of monoamines in the brain caused by the injection of physiologic saline to suckling rats: On the reliability of saline "controls" in neurochemical studies.
    Huether G; Thoemke F; Sprotte U; Steinhaus U; Neuhoff V
    Neurochem Int; 1985; 7(4):725-30. PubMed ID: 20492980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.